Aceragen is a clinical-stage biopharmaceutical company developing therapeutics for rare and orphan pulmonary and rheumatic diseases with high unmet medical need.
Company Location
92 Cornerstone Drive, PMB 133
Cary
NC
27519
County
Region
Company Details
Company type
Year founded
2021
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Potential end market(s)
Products under development
ACG-801, an enzyme replacement therapy for Farber disease; ACG-701, potent anti-infective & anti-inflammatory treatment for melioidosis & CF-related pulmonary exacerbations